With the MiSeq™ i100 Series, Illumina continues to set the highest standards.Advancements in system design, sequencing chemistry, and data analysis deliverthe simplest, fastest benchtop sequencing and ...

Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

Expanding applications of genomics, proteomics, transcriptomics, and metabolomics accelerate clinical development, with North America leading and Asia Pacific emerging as the fastest-growing ...

New BIDMC study on COVID-19 reveals persistent immune activation in patients who developed long COVID, which could help identify new paths to treatment.

New BIDMC Study Reveals Persistent Immune Activation and Paths to TreatmentBOSTON — A new study from investigators at Beth Israel Deaconess Medical ...

Researchers explored this question at ASH and shared data suggesting genomic instability in tumors with high TMB likely ...

Xu, W. , Xing, X. and Cheng, S. (2025) Urine-Based Liquid Biopsy for Detecting Recurrence of Bladder Cancer. International ...

This article is all about what’s new and what it might mean for us, covering the latest in genetics in news. New methods like ...

The United States DNA polymerase market is projected to reach USD 246.9 million by 2035, supported by rising investments in ...

Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its ...

DNAe, the Next-Generation Sequencing (NGS) company developing a transformative fully automated, sample-to-report diagnostics platform, today unveils a new Early Access Program, offering clinical ...

Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its ...